Mr Stefan Balazs > Baker McKenzie > Stockholm, Sweden > Lawyer Profile
Baker McKenzie Offices
VASAGATAN 7, FLOOR 8
PO BOX 180
101 23 STOCKHOLM
Sweden
- Firm Profile
- Go to...
Mr Stefan Balazs
Work Department
Capital Markets
Position
Stefan Balazs is a member of the Firm’s Capital Markets Group in Stockholm and specialized in EU Prospectus and Market Abuse Regulation. Prior to joining Baker McKenzie, Stefan worked in the field of capital market law as a legal counsellor at the Swedish Financial Supervisory Authority (Finansinspektionen), focusing primarily on prospectus law. He has also conducted studies in Business Administration and Economics at the Stockholm University. Furthermore, Stefan is the only Nordic representative of the Consultative Working Group within the Corporate Finance Standing Committee at the European Securities and Markets Authority (ESMA).
Stefan focuses his practice mainly on Equity Capital Markets, Debt Capital Markets, and public mergers & acquisitions. Stefan has extensive transaction experience from representing both issuers and investment banks in IPOs, public capital raisings (preferential rights issues and directed issues), bond listings, MTN-programmes and representing clients in SFSA imposed Market Abuse Regulation-sanctions.
Memberships
- Swedish Bar Association
- Member of the Consultative Working Group of the Corporate Finance Standing Committee within the European Securities and Markets Authority (ESMA)
Education
- University of Stockholm (Juris Kandidat (LL.M.)) (2011)
- University of Stockholm (Business Administration)
Lawyer Rankings
Sweden > Capital markets
Baker McKenzie’s Stockholm office sits at the forefront of the equity capital markets space in Sweden, with the team regularly handling IPOs, including on Nasdaq Stockholm and Nasdaq First North Growth Market, as well as rights issuances, ABBs, and public takeovers. The group is regularly instructed by domestic and international investment banks as underwriters’ counsel and is also noted for its life sciences expertise; acting for several banks in relation to Cinclus Pharma’s main market mid-segment IPO is a recent highlight for the team. Practice head Joakim Falkner has considerable experience representing late-stage private and publicly traded companies, investment banks, investors, shareholders, and sponsors on pre-IPO transactions, IPOs, primary share issuances, and preferential rights offerings. Henric Roth is active in the tech and life sciences spaces. Stefan Balazs and senior associate Johanna Flink are also key contacts.